Idebenone
CAS 58186-27-9
Idebenone (CAS 58186-27-9) is a Phase 4 pharmaceutical compound with 5 bioactivity targets and 111 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | AC50 | 17587.24095238095 nM | 105 | - |
| - | Potency | 21359.960714285717 nM | 26 | - |
| - | IC50 | 20552.631 nM | 19 | - |
| - | MIC | 10000 nM | 7 | - |
| - | EC50 | 732.6 nM | 5 | - |
| - | GI50 | 98000 nM | 1 | - |
| - | Ki | 4000 nM | 1 | - |
| Cytochrome P450 3A4 Enzyme |
IC50 | 5.155 | - | Homo sapiens |
| Cytochrome P450 2D6 Enzyme |
IC50 | 5.523 | - | Homo sapiens |
| Cytochrome P450 2C9 Enzyme |
IC50 | 5.301 | - | Homo sapiens |
| Cytochrome P450 2C19 Enzyme |
IC50 | 6.097 | - | Homo sapiens |
| NAD-dependent protein deacetylase Unclassified |
IC50 | 5.72 | - | Schistosoma mansoni |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Idebenone used for in pharmaceutical contexts?
Idebenone (CAS 58186-27-9) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Idebenone?
Idebenone has 111 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal pain, Activated partial thromboplastin time prolonged, Assisted suicide, Atrial fibrillation, Blood pressure fluctuation. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Idebenone also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for HYDROXYDECYL UBIQUINONE with EU status "restricted".
What clinical phase is Idebenone in?
Idebenone is rendered with ChEMBL max phase 4 (approved).
What bioactivity targets are documented for Idebenone?
Idebenone has 12 bioactivity rows in this page query. Rendered target entries include Cytochrome P450 3A4, Cytochrome P450 2D6, Cytochrome P450 2C9, Cytochrome P450 2C19, NAD-dependent protein deacetylase.